Advanced search
Publication Cover
Acta Cardiologica Volume 65, 2010 - Issue 3
Submit an article Journal homepage
6
Views
1
CrossRef citations to date
0
Altmetric
Review Article

Psoriasis and cardiovascular diseases

Enrico VizzardiDept. of Cardiology, University of Brescia, Italy.Correspondence[email protected]
, MD,
Riccardo RaddinoDept. of Cardiology, University of Brescia, Italy.
, MD,
Melissa TeliDept. of Cardiology, University of Brescia, Italy.
, MD,
Elio GorgaDept. of Cardiology, University of Brescia, Italy.
, MD,
Giulio BrambillaDept. of Cardiology, University of Brescia, Italy.
, MD &
Livio Dei CasDept. of Cardiology, University of Brescia, Italy.
, PhD
Pages 337-340 | Received 05 Nov 2009, Accepted 05 Apr 2010, Published online: 23 May 2017

References

  • Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol 2005; 141: 1537–41.
  • Stern RS, Nijsten T, Feldman SR, Margolis DJ, Rolstad T. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 2004; 9: 136–9.
  • Gelfand JM, Gladman DD, Mease PJ, Smith N, Margolis DJ, Nijsten T, Stern RS, Feldman SR, Rolstad T. Epidemi-ology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 2005; 53: 573.
  • Shbeeb M, Uramoto KM, Gibson LE, O’Fallon WM, Gabriel SE. The epidemiology of psoriatic arthritis inOlmsted County, Minnesota, USA, 1982-1991. J Rheumatol 2000; 27: 1247–50.
  • Krueger JG, Bowcock A. Psoriasis pathophysiology: current concepts of pathogenesis. Ann Rheum Dis 2005; 64 (suppl 2): ii30-ii36.
  • Schon MP, Boehncke WH. Psoriasis. N Engl J Med 2005; 352: 1899–1912.
  • Rocha-Pereira P, Santos-Silva A, Rebelo I, Figueiredo A, Quintanilha A, Teixeira F. The inflammatory response in mild and in severe psoriasis. Br J Dermatol 2004; 150: 917–28.
  • Chodorowska G, Wojnowska D, Juszkiewicz-Borowiec M. C-reactive protein and alpha2-macroglobulin plasma activity in medium-severe and severe psoriasis. J Eur Acad Dermatol Venereol 2004; 18: 180–3.
  • Vanizor Kural B, Orem A, Cimsit G, Uydu HA, Yandi YE, Alver A. Plasma homocysteine and its relationships with atherothrombotic markers in psoriatic patients. Clin Chim Acta 2003; 332: 23–30.
  • Lindegard B. Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban, native Swedes. Dermatologica 1986, 172: 298–304.
  • Henseler T, Christophers E. Disease concomitance in psori-asis. J Am Acad Dermatol 1995; 32: 982–6.
  • Marino MG, Carboni I, De Felice C, Maurici M, Maccari F, Franco E. Risk factors for psoriasis: a retrospective study on 501 outpatients clinical records. Ann Ig 2004, 16: 753–8.
  • Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006; 55: 829–35.
  • Mehta NN, Azfar RS, Shin DB, Neiman AL, Troxel AB, Gelfand JM. Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart J2009 Dec 27 [Epub ahead of print].
  • Kaye JA, Li L, Jick SS. Incidence of risk factors for myocar-dial infarction and other vascular diseases in patients with psoriasis. Br J Dermatol 2008; 159: 895–902.
  • Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA 2006; 296: 1735–41.
  • Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 1985; 13: 450–6.
  • Langley RG, Krueger GG, Griffiths CE. Psoriasis: epi-demiology, clinical features, and quality of life. Ann Rheum Dis 2005; 64 (suppl 2): ii18-ii23.
  • Xiao J, Chen LH, Tu YT, Deng XH, Tao J. Prevalence of myocardial infarction in patients with psoriasis in central China. J Eur Acad Dermatol Venereol 2009; 23: 1311–5.
  • Liu T, Li G. Is atrial fibrillation an inflammatory disease? Med Hypotheses 2005; 64: 1237–8.
  • Liu T, Li L, Korantzopoulos P, Goudevenos JA, Li G. Meta-analysis of association between C-reactive protein and imme-diate success of electrical cardioversion in persistent atrial fibrillation. Am J Cardiol 2008; 101: 1749–52.
  • Liu T, Li G, Li L, Korantzopoulos P. Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis. J Am Coll Cardiol 2007; 49: 1642–8.
  • Korantzopoulos P, Kolettis TM, Galaris D, Goudevenos JA. The role of oxidative stress in the pathogenesis and perpet-uation of atrial fibrillation. Int J Cardiol 2007, 115: 135–43.
  • Markuszeski L, Bissinger A, Janusz I, Narbutt J, Jedrze-jowska AS, Zalewska A. Heart rate and arrhythmia in patients with psoriasis vulgaris. Arch Med Res 2007; 38: 64–9.
  • Gunes Y, Tuncer M, Calka O, Guntekin U, Akdeniz N, Simsek H, Ozdemir IY. Increased frequency of pulmonary hypertension in psoriasis patients. Arch Dermatol Res 2008; 300: 435–40.
  • Nijsten T, Wakkee M. Complexity of the association between psoriasis and comorbidities. J Invest Dermatol 2009; 129: 1601–3.
  • Schmitt J, Ford DE. Psoriasis is independently associated with psychiatric morbidity and adverse cardiovascular risk factors, but not with cardiovascular events in a population-based sample. J Eur Acad Dermatol Venereol 2009 Dec 10 [Epub ahead of print].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Novo Nordisk – Driving change to defeat serious chronic diseases.
Bristol Myers Squibb – symposium on hypertrophic cardiomyopathy.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.